Previous Article | Next Article ![]()
Clinical Microbiology Reviews, Jan 1997, 160-184, Vol 10, No. 1
CM Black
Infections caused by Chlamydia trachomatis are probably the most common
sexually transmitted diseases in the United States. Commonly unrecognized
and often inadequately treated, chlamydial infections can ascend the
reproductive tract and cause pelvic inflammatory disease, which often
results in the devastating consequences of infertility, ectopic pregnancy,
or chronic pelvic pain. C. trachomatis infections are also known to
increase the risk for human immunodeficiency virus infection. The obligate
intracellular life cycle of C. trachomatis has traditionally required
laboratory diagnostic tests that are technically demanding,
labor-intensive, expensive, and difficult to access. In spite of these
historical challenges, however, laboratory diagnosis of C. trachomatis has
been a rapidly advancing area in which there is presently a wide array of
commercial diagnostic technologies, costs, manufacturers. This review
describes and compares the diagnostic methods for C. trachomatis infection
that are currently approved for use in the United States, including the
newest DNA amplification technologies which are yet to be licensed for
commercial use. Issues to consider in selecting a test for purposes of
screening versus diagnosis based on prevalence, performance, legal, social,
and cost issues are also discussed.
Copyright © 1997 by the American Society for Microbiology. All rights reserved.
Current methods of laboratory diagnosis of Chlamydia trachomatis infections
Division of AIDS, Sexually Transmitted Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA. cxb2@ciddas1.em.cdc.gov
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»